David E. Ochayon

584 total citations
18 papers, 381 citations indexed

About

David E. Ochayon is a scholar working on Immunology, Surgery and Molecular Biology. According to data from OpenAlex, David E. Ochayon has authored 18 papers receiving a total of 381 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Immunology, 5 papers in Surgery and 4 papers in Molecular Biology. Recurrent topics in David E. Ochayon's work include Immune Cell Function and Interaction (7 papers), IL-33, ST2, and ILC Pathways (5 papers) and T-cell and B-cell Immunology (4 papers). David E. Ochayon is often cited by papers focused on Immune Cell Function and Interaction (7 papers), IL-33, ST2, and ILC Pathways (5 papers) and T-cell and B-cell Immunology (4 papers). David E. Ochayon collaborates with scholars based in Israel, United States and Uganda. David E. Ochayon's co-authors include Eli C. Lewis, Mark Mizrahi, Galit Shahaf, Stephen N. Waggoner, Ronen Schuster, Ofer Guttman, Eyal Ozeri, Michael T. Borchers, Ren Yi and Nicholas Carriero and has published in prestigious journals such as Immunity, The Journal of Immunology and The Journal of Infectious Diseases.

In The Last Decade

David E. Ochayon

17 papers receiving 376 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David E. Ochayon Israel 10 150 93 87 76 44 18 381
Simona Ceglia Italy 9 137 0.9× 73 0.8× 55 0.6× 199 2.6× 36 0.8× 10 360
Sarah Casulli France 11 168 1.1× 46 0.5× 35 0.4× 113 1.5× 28 0.6× 11 398
Mark Mizrahi Israel 8 118 0.8× 107 1.2× 150 1.7× 105 1.4× 21 0.5× 9 457
Areum Kwak South Korea 10 285 1.9× 107 1.2× 31 0.4× 139 1.8× 30 0.7× 17 452
Adam Idica United States 11 125 0.8× 85 0.9× 79 0.9× 204 2.7× 23 0.5× 20 458
Christine Delprat France 10 215 1.4× 83 0.9× 31 0.4× 171 2.3× 47 1.1× 13 467
Tessa A. M. Steevels Netherlands 11 248 1.7× 28 0.3× 77 0.9× 146 1.9× 30 0.7× 11 438
Eunsom Kim South Korea 8 289 1.9× 120 1.3× 27 0.3× 123 1.6× 24 0.5× 11 401
Shoichi Nishise Japan 11 73 0.5× 91 1.0× 27 0.3× 64 0.8× 17 0.4× 32 299

Countries citing papers authored by David E. Ochayon

Since Specialization
Citations

This map shows the geographic impact of David E. Ochayon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David E. Ochayon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David E. Ochayon more than expected).

Fields of papers citing papers by David E. Ochayon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David E. Ochayon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David E. Ochayon. The network helps show where David E. Ochayon may publish in the future.

Co-authorship network of co-authors of David E. Ochayon

This figure shows the co-authorship network connecting the top 25 collaborators of David E. Ochayon. A scholar is included among the top collaborators of David E. Ochayon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David E. Ochayon. David E. Ochayon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Ochayon, David E., Sandra Andorf, Lisa J. Martin, et al.. (2024). Progressive accumulation of hyperinflammatory NKG2D low NK cells in early childhood severe atopic dermatitis. Science Immunology. 9(92). eadd3085–eadd3085. 8 indexed citations
2.
Ochayon, David E. & Stephen N. Waggoner. (2021). The Effect of Unconventional Cytokine Combinations on NK-Cell Responses to Viral Infection. Frontiers in Immunology. 12. 645850–645850. 14 indexed citations
4.
Ochayon, David E., et al.. (2020). Immunomodulatory effects of cytokine-induced expansion of cytotoxic lymphocytes in a mouse model of lupus-like disease. Cytotherapy. 23(1). 37–45. 2 indexed citations
5.
Ochayon, David E., et al.. (2020). Conditional abrogation of Ddx3x reveals its essential role in lymphocyte development and partial compensation by Y chromosome. The Journal of Immunology. 204(1_Supplement). 223.19–223.19.
6.
Ochayon, David E., et al.. (2020). IL-33 promotes type 1 cytokine expression via p38 MAPK in human NK cells. Journal of Leukocyte Biology. 107(4). 663–671. 34 indexed citations
7.
Gyurova, Ivayla E., Heinrich Schlums, Heidi Sucharew, et al.. (2019). Dynamic Changes in Natural Killer Cell Subset Frequencies in the Absence of Cytomegalovirus Infection. Frontiers in Immunology. 10. 2728–2728. 4 indexed citations
8.
Pokrovskii, Maria, Jason A. Hall, David E. Ochayon, et al.. (2019). Characterization of Transcriptional Regulatory Networks that Promote and Restrict Identities and Functions of Intestinal Innate Lymphoid Cells. Immunity. 51(1). 185–197.e6. 61 indexed citations
9.
Lior, Yotam, David E. Ochayon, Ronen Schuster, et al.. (2018). Point Mutation of a Non-Elastase-Binding Site in Human α1-Antitrypsin Alters Its Anti-Inflammatory Properties. Frontiers in Immunology. 9. 759–759. 7 indexed citations
10.
Sobarzo, Ariel, Spencer W. Stonier, Andrew S. Herbert, et al.. (2016). Correspondence of Neutralizing Humoral Immunity and CD4 T Cell Responses in Long Recovered Sudan Virus Survivors. Viruses. 8(5). 133–133. 7 indexed citations
11.
Ozeri, Eyal, Galit Shahaf, David E. Ochayon, et al.. (2016). Exploration of α1-Antitrypsin Treatment Protocol for Islet Transplantation: Dosing Plan and Route of Administration. Journal of Pharmacology and Experimental Therapeutics. 359(3). 482–490. 11 indexed citations
12.
Sobarzo, Ariel, Andrew S. Herbert, Ana I. Kuehne, et al.. (2015). Immune Memory to Sudan Virus: Comparison between Two Separate Disease Outbreaks. Viruses. 7(1). 37–51. 17 indexed citations
13.
Ochayon, David E., et al.. (2014). Acute Phase Protein α1-Antitrypsin Reduces the Bacterial Burden in Mice by Selective Modulation of Innate Cell Responses. The Journal of Infectious Diseases. 211(9). 1489–1498. 50 indexed citations
14.
Guttman, Ofer, et al.. (2014). Acute-phase protein α1-anti-trypsin: diverting injurious innate and adaptive immune responses from non-authentic threats. Clinical & Experimental Immunology. 179(2). 161–172. 76 indexed citations
15.
Schuster, Ronen, Galit Shahaf, Eyal Ozeri, et al.. (2014). α1-antitrypsin increases interleukin-1 receptor antagonist production during pancreatic islet graft transplantation. Cellular and Molecular Immunology. 11(4). 377–386. 42 indexed citations
16.
Ochayon, David E., et al.. (2013). Human α1-Antitrypsin Binds to Heat-Shock Protein gp96 and Protects from Endogenous gp96-Mediated Injury In vivo. Frontiers in Immunology. 4. 320–320. 26 indexed citations
17.
Mizrahi, Mark, et al.. (2013). Human α1‐antitrypsin modifies B‐lymphocyte responses during allograft transplantation. Immunology. 140(3). 362–373. 19 indexed citations
18.
Ochayon, David E., et al.. (2010). CS1-6 Protection of insulin producing beta cells by the anti-inflammatory acute phase protein alpha-1- antitrypsin. Cytokine. 52(1-2). 6–6. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026